Topical application of antiretroviral drug combination prevents transmission of (S)HIV

(Oak Crest Institute of Science) Findings published last week in the journal PLOS ONE confirm that researchers from the Oak Crest Institute of Science have demonstrated for the first time that two powerful antiretroviral drugs can provide complete protection against HIV when delivered topically by a sustained release intravaginal ring (IVR) device. The combination of tenofovir disoproxil fumarate and emtricitabine delivered at independently controlled rates via the pod-IVR was successful at preventing SHIV162p3 infection for over four months.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news